American Vanguard (AVD) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
3 Jun, 2026Opening remarks and agenda
Meeting called to order virtually at 11:00 A.M. with all board members and key executives present.
Stockholders encouraged to submit questions via webcast, with Q&A scheduled after proceedings.
Corporate governance
Notice of meeting mailed to stockholders of record; quorum established with 75% of voting stock represented.
Stockholders could vote or revoke proxies during the meeting via webcast.
Board and executive committee updates
Seven directors nominated and elected to serve until the 2027 annual meeting.
Key personnel changes and promotions made across commercial, operations, IT, and finance functions.
Partial view of Summaries dataset, powered by Quartr API
Latest events from American Vanguard
- Gross margin and specialty growth offset global headwinds; 2026 guidance reaffirmed.AVD
Q2 2026 - Q1 2026 sales up 7%, gross margin 31%, and adjusted EBITDA up 245% amid strong U.S. crop growth.AVD
Q1 2026 - Annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.AVD
Proxy filing - 2025 margins and EBITDA held steady despite lower sales; 2026 targets growth and improved profitability.AVD
Q4 2025 - Virtual meeting to elect directors, ratify auditor, and approve performance-based executive pay.AVD
Proxy Filing - Q3 loss and sales drop driven by recall, but guidance and non-crop growth remain strong.AVD
Q3 2024 - Q2 sales and margins fell, guidance was cut, and transformation and cost-saving efforts accelerated.AVD
Q2 2024 - Transformation plan aims for 15% EBITDA margin and growth in biologicals by 2025.AVD
Gabelli Funds' 16th Annual Specialty Chemicals Symposium - 2024 EBITDA met guidance as debt and inventory fell; 2025 targets higher revenue and margin.AVD
Q4 2024